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Individuals with schizophrenia (SZ) have been reported to exhibit a higher prevalence of
convergence insufficiency (CI) than the “normal” adult population. The purpose of this
study was to determine if individuals with SZ exhibit clinical signs of CI and to determine
if the Convergence Insufficiency Symptom Survey (CISS) is an effective instrument for
identifying CI in this population. Twenty participants with SZ and 20 healthy controls (HC)
completed the study. The prevalence of CI (15%) in the SZ group was slightly higher than
reported norms, but the difference was not significant.The SZ group had significantly higher
scores on the CISS than the HC group, but the CISS scores did not correlate with clini-
cal measures of CI in individuals with SZ. The only exception was that SZ patients had a
significantly reduced fusional reserve as determined by Sheard’s criteria. Further study is
needed to determine why individuals with SZ reported symptoms associated with CI even
though clinical measures did not support this diagnosis.
Keywords: convergence insufficiency, schizophrenia, vergence, oculomotor, endophenotype, eye movement
dysfunction
INTRODUCTION
Schizophrenia (SZ) is a complex hereditary mental illness that
is characterized by positive, negative, and cognitive symptoms.
The diagnosis is based solely on relatively subjective evaluation
of symptoms, and no objective assessment is currently available
(Tamminga et al., 2010). The etiology and pathophysiology of the
disorder remain poorly understood, and little progress has been
made in developing novel treatments (Insel, 2009).
When studying complex genetic disorders a standard approach
is to search for endophenotypes, as these could provide a bridge
between complex clinical phenotypes and specific genotypes (Rit-
sner, 2009). They are defined as discrete, heritable, genetically
determined variables that are not easily discerned by clinical
assessment but discoverable by a “biochemical test or microscopic
examination” (Lenox et al., 2002; Gottesman and Gould, 2003).
Abnormalities in the visual system, specifically eye movement
dysfunctions, have long been considered as possible endopheno-
types in SZ (Turetsky et al., 2007; Silverstein and Keane, 2011).
Of these, smooth pursuit and saccadic eye movements deficits are
the most replicated findings (Levy et al., 1994; Trillenberg et al.,
2004; Zanelli et al., 2005; O’Driscoll and Callahan, 2008; Rommelse
et al., 2008). These deficits persist even if patients are treated with
antipsychotic medications (Levy et al., 1983; Ulrich and Veena,
2003) and are also found in unaffected relatives of patients with
SZ (Ross et al., 2002; Kathmann et al., 2003; Calkins et al., 2003;
Zanelli et al., 2009).
Because the neural substrates of vergence overlap with those of
smooth pursuit (Gamlin, 2002; Lynch and Tian, 2006), they are
a potentially important class of eye movements to investigate in
patients with SZ. Vergence, a binocular disconjugate eye move-
ment that aligns the eyes to targets at specific depths, became
necessary with the development of binocular vision in foveate pri-
mates and is thought to be cognitively demanding. Levin et al.
(1982) reported a higher rate of intrusive saccades in vergence
tracking in patients with SZ than in healthy controls (HC). In
addition, in a prospective study of high-risk individuals, Schiff-
man et al. (2006) reported a higher rate of binocular alignment
abnormalities in individuals who later developed SZ, suggesting
a possible pre-morbid relationship between oculomotor deficits
and SZ. These results suggest that there might be a link between
vergence eye movements and SZ, but compared to the research
on smooth pursuit and saccadic eye movements relatively little is
known.
One common deficit of vergence eye movements is convergence
insufficiency (CI). CI is a deficit in the ability to converge the eyes
to near targets. Consequences of CI include headaches, blurry and
double vision, and difficulty reading or performing near work.
In contrast to tests of smooth pursuit or antisaccades, CI is rou-
tinely measured in clinical exams. Several studies suggest CI is
present in individuals with SZ (Flach et al., 1992; Hobart et al.,
1999; Chan et al., 2009). However, these reports were based on
subjective judgments of CI. Objective criteria such as measures of
eye position, near point of convergence (NPC), phoria, or positive
fusion vergence ranges were not assessed. To date, there have been
no definitive quantitative studies of CI in individuals with SZ.
The current study was designed to measure objective clinical
signs of CI in individuals with SZ and matched HC. A secondary
goal of the study was to test the validity of the Convergence Insuffi-
ciency Symptom Survey (CISS) for detecting symptoms associated
with CI in patients with SZ. We included 20 stable patients with
SZ and 20 matched HC to test the following hypotheses: (1) com-
pared to HC, patients with SZ will show an increased rate of CI, as
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measured using standard clinical tests and, (2) increased rate of CI
in patients will be correlated with increased numbers of symptoms
reported on the CISS.
MATERIALS AND METHODS
Twenty-four subjects with SZ and schizoaffective disorder were
recruited from the outpatient psychiatry clinic at The University
of Alabama at Birmingham (UAB) to participate in this study.
Twenty-three HC, matched on age, gender, ethnicity, and parental
occupation, were recruited by advertisement in flyers and the
university’s newspaper. Exclusion criteria were major medical con-
ditions, substance abuse within 6 months of enrollment, previous
serious head injury, a neurological disorder, loss of consciousness
for more than 2 min, visual acuity of less than 20/40 in either eye,
more than two lines of difference in visual acuity between the eyes,
or lack of stereopsis. The study was approved by the Institutional
Review Board of the UAB, and all subjects gave written informed
consent. Before signing consent, each SZ subject completed an
Evaluation to Sign Consent Form.
Diagnoses were established using subjects’ medical records and
the Diagnostic Interview for Genetic Studies (DIGS; Nurnberger
et al., 1994). Cognitive function was characterized by the Repeat-
able Battery for the Assessment of Neuropsychological Status
(RBANS; Randolph et al., 1998; Gold et al., 1999; Wilk et al., 2002).
The Brief Psychiatric Rating Scale (BPRS; Overall and Gorham,
1962) and its positive and negative subscales were used to assess
symptom severity.
Each subject was examined by the same physician who was
blind to the psychiatric diagnosis. Three participants (SZ= 1)
were excluded during vision screening and four (SZ= 3) with-
drew or were lost to follow up. Forty participants, 20 SZ and 20
HC, completed the study and were included in the final analyses.
CLINICAL ASSESSMENT
All visual measures were obtained while subjects were stable on
their medication regimen. Distance visual acuity was measured
in each eye with a projected Snellen chart at 20 feet. Near visual
acuity was screened in each eye with a 20/30 isolated line of letters.
Binocular vision testing included fixation disparity (Saladin card),
ocular alignment with cover test at distance and near, NPC break
and recovery, positive fusional vergences (PFV) at near break and
recovery (prism bar), stereo acuity (Randot Stereo), accommoda-
tive amplitudes (push-up) for non-presbyopes, and distance and
near auto-refraction.
Near point of convergence was measured three times with the
Astron International Accommodative Rule (ACR/21; Gulden Oph-
thalmics, Elkins Park, PA, USA) using a printed fixation target with
a single column of 20/30 letters. The target was initially positioned
at eye level, 40 cm from the participant’s bridge and then moved
toward the subject’s eyes until either the subject reported seeing
the target doubled or the examiner noticed a break in fusion (one
eye drifted off target). If the subject was not able to regain fusion,
the distance from the eyes where fusion was lost was noted as
the NPC break point. The target was then pulled away from the
participant’s eyes until fusion was regained and this distance was
documented as the recovery point. The three NPC measures were
averaged for analysis.
Positive fusional vergences were measured three times with a
horizontal prism bar (Gulden B-16 horizontal prism bar) while
the subject fixated a hand-held fixation target (Gulden fixation
stick #15302) with a single column of 20/30 letters held at eye level
at a distance of 40 cm. Base out prism was introduced in gradient
steps on the prism bar while the patient was asked to report if
the target became blurred or double. The prism amounts where
blur and then double vision were reported were recorded as the
blur and break values respectively. Once fusion had been lost, the
prism amount was decreased until fusion was recovered and this
prism amount was recorded as the recovery value. If the examiner
noticed a loss of fusion without the report of double vision, this
value was also recorded as the break value. Three fusional vergence
measures were taken and the results were averaged.
The CISS was administered to each subject at the beginning of
the visit and again at the end of the exam. The survey contains 15
questions regarding how the subject’s eyes feel when reading or
doing close work. The examiner presented questions verbally and
participants were asked to respond with one of the phrases/words
printed on a hand-held card (never, infrequently, sometimes, fairly
often, or always). Each response was scored between 0 (never) and
4 (always) to give a final symptom score range of 0–60. For analysis,
the two symptom scores were averaged.
CLASSIFICATION OF CI
Participants were categorized as having CI if they met the following
three criteria: phoria at near of 4 prism diopters or more greater
exophoria than at distance; a NPC break greater than 5.5 cm, and
near PFV less than 15 prism diopters or failing Sheard’s criteria
PFV less than twice the near phoria, discussed below. Participants
were classified as symptomatic if the CISS average was 21 or greater.
Results for the participants with SZ were compared to published
norms (Daum, 1988; Rouse et al., 2004, 2009). Statistics were
calculated in R (the R project for statistical computing). Group
means were compared using t -tests (two-tailed, Welch correction
for unequal variance) unless otherwise noted.
SHEARD’S CRITERIA
Sheard’s criteria states that patients should have “a fusional ver-
gence reserve at least twice the magnitude of (their) heterophoria”
(Sheard, 1938). Proposed by Sheard in the 1930s, this rule is fre-
quently used by optometrists to prescribe prism. As yet, there have
been few studies to test its validity. The studies that have been
done generally support the validity of Sheard’s criteria, but sug-
gest that it may not detect some patients who are symptomatic
(Daum et al., 1989). Studies also suggest that this test is better at
predicting discomfort in exophores than in esophores (Sheedy and
Saladin, 1978).
RESULTS
GROUP MATCHING
There were no significant differences in age, race, gender, smoking
status, or parental socioeconomic status between the SZ and HC
participant groups (Table 1).
CONVERGENCE INSUFFICIENCY SYMPTOM SURVEY
Eight SZ and one HC met or exceeded the cutoff score of 21 on
the CISS (Figure 1). The mean CISS score (18.6± 9.9) for the
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Table 1 | Demographics and clinical measuresa.
Characteristic HC (n = 20)f SZ (n = 20) t/χ2 p-value
Age, years 36.3±11.3 39.0±11.4 0.75 0.46
Gender, F/M 8/12 9/11 0.10 0.75
Ethnicity, AA/Cb 10/10 14/6 0.94 0.33
Parental SESc 6.7±5.1 6.8±5.0 0.07 0.94
RBANSd
Total index 87.2±12.5 73.7±10.2 6.16 0.002
Immediate memory 88.6±15.3 77.5±12.3 6.43 0.03
Visuospatial 79.9±15.7 79.9±15.7 2.31 0.69
Language 95.5±14.4 87.3±13.7 2.95 0.11
Attention 96.4±20.8 82.3±12.9 4.58 0.03
Delayed memory 91.8±8.4 72.5±20.7 5.38 0.001
BPRSe
Total – 29.2±6.8 – –
Positive – 4.5±2.6 – –
Negative – 4.3±2.0 – –
χ2 includes Yate’s correction.
aMean±SD unless indicated otherwise; SZ, schizophrenia; HC, healthy control.
bAA, African American; C, Caucasian.
cSocioeconomic Status; Ranks determined from Diagnostic Interview for Genetic
Studies (1–18 scale); higher rank (lower numerical value) corresponds to higher
socioeconomic status; information not available for one SZ.
dRepeatable Battery for the Assessment of Neuropsychological Status; data not
available for two SZ and two HC.
eBrief Psychiatric Rating Scale (1–7 scale); positive (conceptual disorganization,
hallucinatory behavior, and unusual thought content); negative (emotional with-
drawal, motor retardation, and blunted affect); data not available for two SZ.
f18 SZ were treated with second generation antipsychotics and two SZ were not
taking antipsychotics.
SZ group was significantly higher than that of the HC group
(9.9± 5.5). In addition, the SZ group exhibited significantly
(p= 0.002) higher CISS scores than those reported for subjects
with normal binocular vision and stereopsis, regardless of whether
they also had CI (11.0± 8.2; Rouse et al., 2004).
CLINICAL MEASURES
CI criteria measures
Three of the SZ participants and one of the HC participants met all
three of the diagnostic criteria and were classified as convergence
insufficient (Table 2). Seven SZ and six HC had a receded NPC.
The mean NPC for the SZ and HC groups were 5.5 and 4.4 cm
respectively, which was not a significant difference (p= 0.207).
Eight SZ and nine HC met the cover test criteria for CI. The mean
phoria difference in the cover test for the SZ group was −3.95
prism diopters while the HC group was −2.35 prism diopters.
The phoria differences between groups were also not significant
(p= 0.626). Seven SZ and one HC failed Sheard’s criteria. This dif-
ference was significant (p= 0.022). With our cutoff values, the chi-
square test for differences between NPC and phoria classifications
were not significant (p= 0.736, p= 0.749 respectively).
Interrelation of CI clinical measures
Highly significant correlations were found between all of the mea-
sures used to form the CI criteria (all p< 0.0005) in the entire
FIGURE 1 | Distribution of mean CISS scores in each participant group.
Bold vertical line indicates the cutoff score of 21. Individuals scoring≥21 on
the CISS were considered as having symptoms consistent with CI. (A) SZ,
schizophrenia patients. (B) HC, healthy controls. CISS, Convergence
Insufficiency Symptom Survey.
Table 2 | Convergence insufficiency symptom survey scores and CI
clinical measures, between group comparisonsa.
Criterion measure HC (N =20) SZ (N =20) t/χ2 p-Value
CISS 9.9±5.5 18.6±9.9 t =3.43 0.001
<21 19 12
≥21 1 8
CI
CI negative 19 17 Fischer 0.60
CI positive 1 3 Exact test
NPC criteria
≤5.5 cm 14 13 χ2=0.11 0.73
>5.5 cm 6 7
Sheard’s criteria
True 1 7 Fischer 0.02
False 19 13 Exact test
Phoria criteria
True 9 8 χ2=0.10 0.75
False 11 12
NPC break (cm) 4.4±2.37 5.5±2.95 t =1.30 0.20
NPC recover (cm) 6.88±3.28 8.45±3.02 t =1.57 0.12
Cover test (PDb) −2.35±3.45 −3.95±6.76 t =0.94 0.35
χ2 statistic includes Yate’s correction. Fischer’s exact test was used when there
were less than five cases in a cell in a given contingency table.
aMean±SD unless indicated otherwise; SZ, schizophrenia; HC, healthy control.
bPD prism diopters, near phoria – distance phoria.
cohort, this was also true when only SZ participants (all p< 0.05)
or HC participants (all p< 0.05) were included in the analysis.
Relationship of CISS scores and clinical measures in the SZ group
Eight SZ participants exceeded the cutoff score of 21 on the CISS
(Table 2). However, there were no significant differences in NPC
break or recovery, vergence break or recovery, distance or near
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Table 3 | SZ CISS scores and CISS classification frequency by CI
diagnosisa.
CISS scores CI positive CI negative
Mean 15.83±1.25 19.06±10.72
n<21 3 9
n≥21 0 8
aMean ± SD unless indicated otherwise; SZ, schizophrenia; CISS, Convergence
Insufficiency Symptom Survey.
phoria, phoria differences at near vs. distance, stereo acuity, or fix-
ation disparity between the SZ participants who scored at or above
the CISS cutoff and those who scored below the cutoff.
The mean CISS score for the SZ participants with CI did not
significantly differ from those without (with CI: 15.83; without CI:
19.06; p> 0.05). The three SZ participants who met the clinical
criteria for CI all scored below 21 on the CISS (Table 3). There
was no significant relationship between the CISS scores and any
clinical measure of CI.
Relationship of CISS and clinical CI measures with psychometric
tests
As expected, SZ and HC had significantly different scores on the
RBANS (p= 0.002). In the SZ group there was no significant dif-
ference between those who scored 21 or above on the CI and
those who did not on the BPRS total, BPRS negative or positive
subscales scores, the RBANS total or its subscales scores. There
was no significant correlation between the CISS mean scores and
any of the psychometric total scores or subscale scores in either
group.
There was no significant difference between SZ with CI and
those without and any of the psychometric total scores or sub-
scale scores. There was no significant correlation between the
NPC break, phoria measures, or vergence ductions and any of
the psychometric total scores or sub scores.
DISCUSSION
In this study, we compared objective clinical measures of CI with
the CISS subjective self-reports of CI symptoms in a group of
stable patients with SZ, and matched HC. Contrary to our ini-
tial hypotheses, we found that patients with SZ did not exhibit CI
more frequently than HC, although their CISS-based self-report
measures suggested the opposite.
The two eye movement deficits that have been most exten-
sively studied in SZ, smooth pursuit gain and antisaccade error
rate, are neither specific to the disorder nor present in all patients
with SZ (Holzman, 2000; Hutton et al., 2004; Levy et al., 2004;
Donohoe et al., 2006). They do however provide insights into the
neuropathology of SZ and have proved to be useful endopheno-
types by reducing heterogeneity in genetic studies of SZ (Calkins
et al., 2008). Because the neural substrates of vergence eye move-
ments overlap those of smooth pursuit (Lynch and Tian, 2006),
they are a particularly important class of eye movements to inves-
tigate in patients with SZ. In addition, if in fact abnormal ver-
gence eye movements are associated with SZ then, because CI
is routinely measured in clinical exams, large-scale characteri-
zation of vergence eye movement dysfunction in SZ would be
possible.
Only one objective measure of CI was found to be significantly
different between the groups: SZ met Sheard’s criteria more fre-
quently than HC. This difference may indicate that, even though
the patients have normal ranges of convergence, they have less
reserve capacity and may experience binocular vision problems
when fatigued. This is potentially clinically relevant as oculomo-
tor dysfunction related to binocular vision problems such as CI,
could negatively impact the ability of a patient to achieve optimal
function (Reding and Potes, 1988; Groswasser et al., 1990). We
speculate that if vision therapy for CI could enhance the reserve
capacity for convergence, conceivably this could assist in cognitive
remediation in SZ and thus help alleviate the greatest contribu-
tor to poor functional outcomes (Wykes et al., 2011). Additional
research on the effects of vision therapy on convergence reserve
capacity, and its interactions with SZ, may be called for.
The finding that SZ patients do not exhibit CI does not necessar-
ily rule out all problems with vergence eye movements. Since CI is
a measure of static alignment of the two eyes in near space, it does
not require the dynamic sensorimotor transformation required
for accomplishing rapid vergence eye movement or tracking-in-
depth tasks. The eye movement abnormalities in SZ patients have
previously been identified in tasks that require integrating visual
information across space and time with a motor output (Chen
et al., 2011). Consistent with this, in a preliminary study, we have
observed that SZ patients have lowered dynamic vergence tracking
gain compared to controls (Bolding et al., 2012).
Interestingly, we found no correlation between the CI clini-
cal measures and CISS ratings in the SZ group. Of the three SZ
participants diagnosed with CI, none had a CISS score greater
than or equal to 21. In the general population, the CISS has shown
good sensitivity (97.8%) for identifying symptomatic CI individu-
als (Rouse et al., 2004), however this was not true when we applied
this to our cohort of SZ patients. Eight participants in the SZ group
scored 21 or greater on the CISS although they did not have objec-
tive findings consistent with CI. It is possible that patients did not
understand the CISS questions. If this were the case, we would
expect the CISS scores to negatively correlate with the RBANS
scores. However, the CISS scores did not correlate with the RBANS
scores or any of its subscales, which indicates that the unexpected
high number of false positives is not directly contributable to cog-
nitive deficits. More likely, the large number of false positives on
the CISS in the SZ group may suggest that SZ participants experi-
ence some visual difficulties related to CI, possibly some dynamic
aspect of vergence eye movements not measured by the clinical
tests of CI.
In conclusion, contrary to our initial hypothesis, patients with
SZ did not exhibit a higher prevalence of CI, although there was
evidence for a reduced convergence reserve capacity as defined
by Sheard’s criteria. However, 40% of them did report subjective
symptoms associated with CI as reported by the CISS. Based on
our results, we propose that current clinical CI testing is not an
adequate tool to assess prevalence of binocular vision deficits in
individuals with SZ. Further study is needed to determine why
individuals with SZ are reporting symptoms associated with CI
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even though standard static clinical measures do not reveal a
deficit. The development of simple and robust clinical tests of
the dynamics of vergence eye movements, and their application as
a research tool in SZ, may prove to be of particular utility.
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